Earnings Play Canopy Growth
How to play Canopy Growth's earnings
Share this:
On Friday, before market, Canopy Growth (CGC) is anticipated to release 4Q LPS of $0.52 on revenue of approximately $128.9M vs. $94.1M last year. The company cultivates and sells medicinal and recreational cannabis, and its current analyst consensus rating is 10 buys, 11 holds and 0 sells, according to Bloomberg.
From a technical point of view, Canopy Growth's stock price is holding above the 200-day moving average which price gapped over at the start of the trading week on Tuesday. Price has been advancing in a rising channel that began to form in mid-March. The RSI has also been rising on top of an upward trend line and is currently above 70. Price has upward momentum and is breaking to the upside of the upper trend line and on the way to the $25.00 resistance level. If price can break above the $25.00 level we may see a move towards the $29.00 level. If price cannot manage to hold above the 200-day moving average and falls below its last peak and weekly low around $18.25, then price could potentially make its way to the lower trend line.
Source: GAIN Capital, TradingView
From a technical point of view, Canopy Growth's stock price is holding above the 200-day moving average which price gapped over at the start of the trading week on Tuesday. Price has been advancing in a rising channel that began to form in mid-March. The RSI has also been rising on top of an upward trend line and is currently above 70. Price has upward momentum and is breaking to the upside of the upper trend line and on the way to the $25.00 resistance level. If price can break above the $25.00 level we may see a move towards the $29.00 level. If price cannot manage to hold above the 200-day moving average and falls below its last peak and weekly low around $18.25, then price could potentially make its way to the lower trend line.
Source: GAIN Capital, TradingView
On Friday, before market, Canopy Growth (CGC) is anticipated to release 4Q LPS of $0.52 on revenue of approximately $128.9M vs. $94.1M last year. The company cultivates and sells medicinal and recreational cannabis, and its current analyst consensus rating is 10 buys, 11 holds and 0 sells, according to Bloomberg.
From a technical point of view, Canopy Growth's stock price is holding above the 200-day moving average which price gapped over at the start of the trading week on Tuesday. Price has been advancing in a rising channel that began to form in mid-March. The RSI has also been rising on top of an upward trend line and is currently above 70. Price has upward momentum and is breaking to the upside of the upper trend line and on the way to the $25.00 resistance level. If price can break above the $25.00 level we may see a move towards the $29.00 level. If price cannot manage to hold above the 200-day moving average and falls below its last peak and weekly low around $18.25, then price could potentially make its way to the lower trend line.
Source: GAIN Capital, TradingView
From a technical point of view, Canopy Growth's stock price is holding above the 200-day moving average which price gapped over at the start of the trading week on Tuesday. Price has been advancing in a rising channel that began to form in mid-March. The RSI has also been rising on top of an upward trend line and is currently above 70. Price has upward momentum and is breaking to the upside of the upper trend line and on the way to the $25.00 resistance level. If price can break above the $25.00 level we may see a move towards the $29.00 level. If price cannot manage to hold above the 200-day moving average and falls below its last peak and weekly low around $18.25, then price could potentially make its way to the lower trend line.
Source: GAIN Capital, TradingView
Latest market news
The complete CFD trading experience
Award-winning platforms, competitive spreads, low commissions and dedicated support.
We live and breathe the markets and are dedicated to helping traders realise their ambitions as we continue to set the industry bar.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.
Related articles
S&P 500, Nasdaq, Dow Forecast: Rising Yields Test Rally Ahead of Nvidia, Fed 8 22 2026
S&P 500, Nasdaq and Dow test key technical levels as momentum fades, raising the risk of a deeper correction heading into a pivotal week.
GBP/USD, Dow Jones Forecast: Key Technical Scenarios to Watch
GBP/USD and the Dow Jones are approaching critical technical levels amid earning optimism, Fed rate hike expectations, US-Iran developments, and persistent geopolitical risks.
The U.S. Dollar Is Rising Again and Nasdaq Is Feeling It
Nasdaq, the U.S. Dollar Index and Federal Reserve expectations are driving market sentiment ahead of a pivotal FOMC meeting. Razan Hilal, StoneX Market Analyst, explains how rising expectations for a hawkish Federal Reserve, persistent U.S.-Iran tensions and key technical levels on the U.S. Dollar Index could influence currencies, equities and precious metals in the weeks ahead.
StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.
StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.